![Emilio José Ayanz Guillén](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emilio José Ayanz Guillén
Private Equity Investor bij Fundación Creas Valor Social /Private Equity/
Profiel
Emilio José Ayanz Guillén is the founder of Minerva Capital SL, which was founded in 2004.
He held the title of Partner from 2004 to 2009.
Currently, he is the Managing Partner at Fundación Creas Valor Social since 2019.
Mr. Ayanz Guillén's former positions include Investment Director at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA from 2012 to 2018, and Director at Iden Biotechnology SL.
Actieve functies van Emilio José Ayanz Guillén
Bedrijven | Functie | Begin |
---|---|---|
Fundación Creas Valor Social /Private Equity/
![]() Fundación Creas Valor Social /Private Equity/ Investment ManagersFinance Fundación Creas Valor Social is a venture capital and private equity operating division of Fundacion Creas Valor Social founded in 2007 by Luis Berruete and Pedro J. Armentia. The firm is headquartered in Zaragoza, Spain. | Private Equity Investor | 01-01-2019 |
Eerdere bekende functies van Emilio José Ayanz Guillén
Bedrijven | Functie | Einde |
---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
![]() Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | 31-07-2018 |
Minerva Capital SL
![]() Minerva Capital SL Investment ManagersFinance Minerva Capital SL (Minerva Capital) is an independent Spanish private equity firm which was established in 2004 by David N. Bendel, Alfonso Lopez-Quesada and Emilio J. Ayanz Guillen to act as an adviser and manager of buy-outs of Spanish small and medium-sized companies. Located in Madrid, Minerva Capital is dedicated to sourcing, advising and managing buyouts of small and medium-sized companies, structuring their investments through bilateral co-investment type arrangements. | Oprichter | 01-01-2009 |
Iden Biotechnology SL
![]() Iden Biotechnology SL BiotechnologyHealth Technology Iden Biotechnology SL provides biotechnological research and development services for agricultural applications. It offers applications in the production of high-yield, climate-resistant crops for food, energy, pharmaceuticals, and animal feeds. The firm also provides solutions for technology scouting, intellectual property brokering and licensing, research project management, and competitive intelligence. The company was founded by Nora Alonso on May 30, 2005 and is headquartered in Cordovilla, Spain. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Minerva Capital SL
![]() Minerva Capital SL Investment ManagersFinance Minerva Capital SL (Minerva Capital) is an independent Spanish private equity firm which was established in 2004 by David N. Bendel, Alfonso Lopez-Quesada and Emilio J. Ayanz Guillen to act as an adviser and manager of buy-outs of Spanish small and medium-sized companies. Located in Madrid, Minerva Capital is dedicated to sourcing, advising and managing buyouts of small and medium-sized companies, structuring their investments through bilateral co-investment type arrangements. | Finance |
Iden Biotechnology SL
![]() Iden Biotechnology SL BiotechnologyHealth Technology Iden Biotechnology SL provides biotechnological research and development services for agricultural applications. It offers applications in the production of high-yield, climate-resistant crops for food, energy, pharmaceuticals, and animal feeds. The firm also provides solutions for technology scouting, intellectual property brokering and licensing, research project management, and competitive intelligence. The company was founded by Nora Alonso on May 30, 2005 and is headquartered in Cordovilla, Spain. | Health Technology |
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
![]() Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
Fundación Creas Valor Social /Private Equity/
![]() Fundación Creas Valor Social /Private Equity/ Investment ManagersFinance Fundación Creas Valor Social is a venture capital and private equity operating division of Fundacion Creas Valor Social founded in 2007 by Luis Berruete and Pedro J. Armentia. The firm is headquartered in Zaragoza, Spain. | Finance |